Cent Eur J Public Health 2011, 19(3):131-133 | DOI: 10.21101/cejph.a3635

Serologic Survey of Humans for Flavivirus West Nile in Southern Moravia (Czech Republic)

Zdeněk Hubálek1, Bohumír Kříž2, Jiří Halouzka1
1 Institute of Vertebrate Biology, Academy of Sciences, Brno, Czech Republic
2 National Institute of Public Health, Prague, Czech Republic

A serosurvey for West Nile virus (WNV) was carried out in 525 persons, using a plaque-reduction neutralization microtest (PRNµT) with Vero cells and Egyptian topotype Eg-101 strain as test virus. The blood sera were collected in four South-Moravian districts (Hodonín 44 persons, Břeclav 102 persons, Znojmo 170 persons, Jihlava 209 persons) of the Czech Republic in the years 1988 and 1989, and stored at -20°C. Antibodies to WNV were detected in only three humans (0.6% seropositivity): one person each in the districts of Hodonín (2.3% persons positive), Břeclav (1.0% positive) and Jihlava (0.5% positive), with the titres of 1:64, 1:32, and 1:32, respectively. All the three sera were negative for antibody to tick-borne encephalitis virus. The results indicate that activity of WNV in southern Moravia was very low before 1990.

Keywords: West Nile virus, Flavivirus, Moravia, Czech Republic, serosurvey

Received: August 10, 2010; Revised: June 2, 2011; Accepted: June 2, 2011; Published: September 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hubálek Z, Kříž B, Halouzka J. Serologic Survey of Humans for Flavivirus West Nile in Southern Moravia (Czech Republic). Cent Eur J Public Health. 2011;19(3):131-133. doi: 10.21101/cejph.a3635. PubMed PMID: 22026285.
Download citation

References

  1. Hubálek Z, Halouzka J, Juricová Z, Sebesta O. First isolation of mosquito-borne West Nile virus in the Czech Republic.Acta Virol. 1998 Apr;42(2):119-20.
  2. Hubálek Z, Savage HM, Halouzka J, Juricová Z, Sanogo YO, Lusk S. West Nile virus investigations in South Moravia, Czechland. Viral Immunol. 2000;13(4):427-33. Go to original source... Go to PubMed...
  3. De MadridAT, Porterfield JS.Asimple micro-culture method for the study of group B arboviruses. Bull World Health Organ. 1969;40(1):113-21. Go to PubMed...
  4. De Madrid AT, Porterfield JS. The flaviviruses (group B arboviruses): a cross-neutralization study. J Gen Virol. 1974 Apr;23(1):91-6. Go to original source... Go to PubMed...
  5. Hubálek Z, Chanas AC, Johnson BK, Simpson DI. Cross-neutralization study of seven California group (Bunyaviridae) strains in homoiothermous (PS) and poikilothermous (XTC-2) vertebrate cells. J Gen Virol. 1979 Feb;42(2):357-62. Go to original source... Go to PubMed...
  6. Theiler M, Downs WG. The arthropod-borne viruses of vertebrates. New Haven and London: Yale University Press; 1973.
  7. Calisher CH, Karabatsos N, Dalrymple JM, Shope RE, Porterfield JS, Westaway EG, et al. Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. J Gen Virol. 1989 Jan;70 (Pt 1):37-43. Go to original source... Go to PubMed...
  8. Weingartl HM, Drebot MA, Hubálek Z, Halouzka J,Andonova M, Dibernardo A, et al. Comparison of assays for the detection of West Nile virus antibodies in chicken serum. Can J Vet Res. 2003 May;67(2):128-32.
  9. Niedrig M, Sonnenberg K, Steinhagen K, Paweska JT. Comparison of ELISA and immunoassays for measurement of IgG and IgM antibody to West Nile virus in human sera against virus neutralisation. J Virol Methods. 2007 Jan;139(1):103-5. Go to original source... Go to PubMed...
  10. Labuda M, Kožuch O, Grešíková M. Isolation of West Nile virus from Aedes cantans mosquitoes in West Slovakia. Acta Virol. 1974 Sep;18(5):429-33.
  11. Bakonyi T, Hubálek Z, Rudolf I, Nowotny N. Novel flavivirus or new lineage of West Nile virus, central Europe. Emerg Infect Dis. 2005 Feb;11(2):225-31. Go to original source... Go to PubMed...
  12. Samoilova TI, Votiakov VI, Titov LP. Virologic and serologic investigations of West Nile virus circulation in Belarus. Cent Eur J Public Health. 2003 Jun;11(2):55-62.